Ni K, Hawkins RM, Smyth HL, Seggelke SA, Gibbs J, Lindsay MC, Kaizer LK, Low Wang CC. Safety and Efficacy of Insulins in Critically Ill Patients Receiving Continuous Enteral Nutrition. Endocr Pract. 2024 Apr;30(4):367-371. PubMed PMID: 38307456
Wang YJ, Seggelke S, Hawkins RM, Gibbs J, Lindsay M, Hazlett I, Low Wang CC, Rasouli N, Young KA, Draznin B. IMPACT OF GLUCOSE MANAGEMENT TEAM ON OUTCOMES OF HOSPITALIZARON IN PATIENTS WITH TYPE 2 DIABETES ADMITTED TO THE MEDICAL SERVICE. Endocr Pract. 2016 Dec;22(12):1401-1405. PubMed PMID: 27540884
Wang CCL, Seggelke S, Hawkins RM, Cohlmia E, Gibbs J, Rasouli N, and Draznin B. Transitional Care Clinic for Patients with Diabetes May Prevent Re-Hospitalizations. Diabetes 2013;July supplement. (in press). 1217-P. Selected for Guided Audio Poster Tour.
Hsia E, Seggelke SA, Gibbs J, Rasouli N, Draznin B.(2011) Comparison of 70/30 biphasic insulin with glargine/lispro regimen in non-critically ill diabetic patients on continuous enteral nutrition therapy. Nutrition in Clinical Practice. 26(6):714-7.
Seggelke, SA, Gibbs, J, Draznin, B. (2011). Neutral protamin hagedorn insulin to conteract the effect of methylprednisone in hospitalized patients with diabetes. Journal of Hospital Medicine. 6(3): 175-176.